BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4640264)

  • 1. [Therapeutic value of a new original oral antidiabetic with vascular action: gliclazide (SE-1702)].
    Canivet J
    Therapeutique; 1972; 48(7):457-62. PubMed ID: 4640264
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
    Simonin R
    Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845
    [No Abstract]   [Full Text] [Related]  

  • 3. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
    Masbernard A; Portal A
    Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of an oral antidiabetic with vascular action: gliclazide in the asymptomatic diabetes and patent diabetes].
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():331-9. PubMed ID: 1011422
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic value of a new oral antidiabetic agent: gliclazide].
    Bernasconi D; Mazzi C
    Clin Ter; 1978 Mar; 84(6):627-35. PubMed ID: 648108
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
    Jaillard J; Warembourg H
    Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic value of a new hypoglycemic agent (gliclazide) in the treatment of diabetes mellitus].
    Polosa P; Mughini L
    Clin Ter; 1978 Jan; 84(2):135-40. PubMed ID: 648096
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gliclazide, a new antidiabetic with hemobiologic and vascular properties].
    Plauchu M; Pousset G
    Lyon Med; 1972 Oct; 228(16):383-5. PubMed ID: 4637685
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trial with a new oral antidiabetic, gliclazid, in general practice (author's transl)].
    Villiger U
    Schweiz Rundsch Med Prax; 1982 Apr; 71(16):699-704. PubMed ID: 7050960
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of insulin and sulfonylurea derivatives on chronic intravascular microcoagulation of the blood in diabetes mellitus].
    Velikov VK; Galkina AK; Bokarev IN; Frolova AI; Shubina OI
    Sov Med; 1985; (9):91-3. PubMed ID: 3906934
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial of glypizide].
    CaƱadell Vidal J
    Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with diamicron treatment of diabetics].
    Velikov VK; Shubina IO; Saltykov BB; Frolova AI
    Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypoglycemic effect of diamicron in diabetic patients].
    Balabolkin MI; Morozova TP; Zhizhina SA; Gavriliuk LI
    Klin Med (Mosk); 1983 Jan; 61(1):87-9. PubMed ID: 6834765
    [No Abstract]   [Full Text] [Related]  

  • 15. [[Early results of the treatment of diabetes with a (methyl-4-phenylsulfonyl)-1-[perhydrocyclopenta(C)pyrrolyl-2]-3-urea (gliclazide)].
    Montenero P; Leotta S
    Clin Ter; 1978 Aug; 86(4):319-35. PubMed ID: 737962
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term ambulatory treatment of diabetics with gliclazide].
    Parodi FA
    Clin Ter; 1979 Feb; 88(3):281-8. PubMed ID: 376219
    [No Abstract]   [Full Text] [Related]  

  • 17. Gliclazide (diamicron) in metabolic and vascular treatment of diabetes mellitus.
    Forette B
    East Afr Med J; 1977 Oct; 54(10):579-81. PubMed ID: 608430
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long term study of a new antidiabetic agent in 1183 cases].
    Riveline B
    Sem Hop Ther; 1974 Feb; 50(2):133-9. PubMed ID: 4612707
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024.
    Parodi FA
    Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831
    [No Abstract]   [Full Text] [Related]  

  • 20. Small vessel disease in diabetes-pathogenesis. Introduction.
    Pfeiffer EF
    Acta Diabetol Lat; 1971 Sep; 8 Suppl 1():217-27. PubMed ID: 5146906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.